A personal trainer was sentenced today to 31 months in jail for selling and supplying unlicensed and prescription medicines, together with Anabolic steroids, to the public.
Middle EastExplainer: Who decides if the world needs COVID-19 booster shots?
Julie SteenhuysenKate Kelland
4 minute read
Vials labelled AstraZeneca, Pfizer - Biontech, Johnson&Johnson, Sputnik V coronavirus disease (COVID-19) vaccine are seen in this illustration picture taken May 2, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Vaccine makers Moderna Inc and Pfizer Inc, with its German partner BioNTech, have been vocal in their view that the world will soon need COVID-19 booster shots to maintain high levels of immunity. read more What is less clear, however, is who should make that decision - and based on what evidence.
THE MODEL FOR FLU VACCINES
EXPLAINER-Who decides if the world needs COVID-19 booster shots? Reuters 3 hrs ago
By Julie Steenhuysen and Kate Kelland
May 13 (Reuters) - Vaccine makers Moderna Inc and Pfizer Inc, with its German partner BioNTech, have been vocal in their view that the world will soon need COVID-19 booster shots to maintain high levels of immunity. What is less clear, however, is who should make that decision - and based on what evidence.
THE MODEL FOR FLU VACCINES
Public health officials have a well-coordinated mechanism, first established in 1952, for determining when seasonal flu vaccines should be updated to cope with fast-mutating strains of influenza.
Vaccine makers Moderna Inc and Pfizer Inc, with its German partner BioNTech, have been vocal in their view that the world will soon need COVID-19 booster shots to maintain high levels of immunity. What is less clear, however, is who should make that decision - and based on what evidence.
THE MODEL FOR FLU VACCINES Public health officials have a well-coordinated mechanism, first established in 1952, for determining when seasonal flu vaccines should be updated to cope with fast-mutating strains of influenza. The World Health Organization s Global Influenza Surveillance and Response System gathers data collected by national health authorities on circulating flu strains and, twice a year, uses that information to select the strains manufacturers should include in seasonal shots for the Northern and Southern Hemispheres. Some experts have suggested a similar model could be used to gather data on COVID-19 variants and advise drugmakers on what to include in vaccine updates.
4 Min Read
(Reuters) - Vaccine makers Moderna Inc and Pfizer Inc, with its German partner BioNTech, have been vocal in their view that the world will soon need COVID-19 booster shots to maintain high levels of immunity. What is less clear, however, is who should make that decision - and based on what evidence.
FILE PHOTO: Vials labelled AstraZeneca, Pfizer - Biontech, Johnson&Johnson, Sputnik V coronavirus disease (COVID-19) vaccine are seen in this illustration picture taken May 2, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
THE MODEL FOR FLU VACCINES
Public health officials have a well-coordinated mechanism, first established in 1952, for determining when seasonal flu vaccines should be updated to cope with fast-mutating strains of influenza.